Protease-activated receptors (PARs) belong to the family of membrane receptors coupled to G-proteins; their presence is reported in a wide variety of cells. The object of this study was to demonstrate the presence of PAR-1 and PAR-2 in myenteric glia of the guinea pig, and to elucidate the cellular mechanisms that are triggered upon receptor activation. ] i . PAR-1 and PAR-2 were localized in myenteric glia by immunolabeling. Our results indicate that PAR-1 and PAR-2 are present in myenteric glia of the guinea pig, and their activation leads to increases in intracellular calcium via different signal transduction mechanisms that involve activation of phospholipase C and sphingosine kinase.
3 The enteric nervous system (ENS) regulates secretion, absorption, motility and vascular reactivity of the gastrointestinal tract. The ENS diverges functionally and structurally from other divisions of the PNS, maintaining integrated function in the absence of input from the CNS, and containing non-neuronal cell populations that resemble CNS astrocytes (Jessen and Mirsky 1983; Gershon and Sherman 1987) . The two major cell types that constitute the ENS, neurons and glia, are present in a ratio of 1 : 2 (Gabella 1982) . Recent evidence suggests that enteric glia are functionally active in information transfer in the ENS. Protease-activated receptors (PARs) belong to a G-protein-coupled family of receptors. Most studies of PARs have been related to cellular responses to injury and inflammation (Vergnolle et al. 2001) . PARs become activated through a unique mechanism that involves proteolytic cleavage of the extracellular N-terminal domain, exposing a new N-terminus that acts as a tethered ligand, binding and activating the receptor itself. To date, four different PARs have been cloned. PAR-1 and PAR-3 are activated by thrombin; PAR-2 is activated by trypsin and mast cell tryptase; and PAR-4 is activated by both trypsin and thrombin (Vu et al. 1991 4 ; Nystedt et al. 1995 5 ; Ishihara et al. 1997; Xu et al. 1998) . PARs have been localized to a variety of tissues and cell types, including the CNS. In the ENS, the presence of PARs has been reported in submucosal and myenteric neurons (Corvera et al. 1999; Green et al. 2000) . The presence of PARs in enteroglial cells has not yet been established.
The object of this study was to demonstrate the presence of PAR-1 and PAR-2 in myenteric glial cells, and to elucidate the cellular mechanisms that are triggered upon receptor activation. We report that PAR-1 and PAR-2 are expressed and are functionally active in myenteric glial cells of the guinea pig. The current study demonstrates the existence of receptor-specific signal transduction mechanisms that involve activation of phospholipase C (PLC) and sphingosine kinase following PAR occupation in enteric glia.
Materials and methods

Materials
Trypsin was from Worthington Biochemicals (Lakewood, NJ, USA). Dimethylsphingosine (DMS), penicillin-streptomycin solution, tetrodotoxin (TTX), thrombin and collagenase type V were obtained from Sigma (St Louis, MO, USA). U-73343 and U-73122 were purchased from RBI (Natick, MA, USA). Fura-2 acetoxymethyl ester and fura-2 free acid were from Molecular Probes (Eugene, OR, USA). Recombinant human tryptase was from Promega (Madison, WI, USA). PAR peptide (PARP) receptor antagonists (PARP-1: TFLLR-NH2; PARP-2: tc-LIGRO-NH2) were a kind gift from Dr Nigel Bunnet (Department of Surgery and Physiology, University of California, San Francisco 6 , CA, USA). The primary antibodies for PAR-1, PAR-2, c-fos and glial fibrillary acidic protein (GFAP) were from Santa Cruz (La Joya, CA, USA). Hank's balanced salt solution, M199 culture media and L-glutamine were from GibcoBRL (Grand Island, NJ, USA) .
Cell culture
Primary cultures of guinea pig myenteric plexus were obtained as described previously (Kimball and Mulholland 1996) . Briefly, tenia coli from 1-day-old male Duncan-Hartley guinea pigs (Simonsen, Gilroy, CA, USA) were removed and placed in collagenase for 18-20 h at 4°C, followed by 30 min incubation at 37°C. The layers of longitudinal and circular muscle were separated from the myenteric plexus using a dissecting microscope. The plexus was treated with a trypsin-EDTA solution for 30 min at 37°C to allow enzymatic digestion of the tissue. After a brief centrifugation (2000 g for 5 min), the cell pellet was mechanically disaggregated, and then plated in collagen-coated glass coverslips. The cultures were maintained in M199 complete medium supplemented with 5% BD TM Nu-Serum, and 0.001% trypsin inhibitor (type I-S from soybean). For the first 48 h, penicillin-streptomycin solution was added to the cultures at 2% dilution. The cultures were incubated at 37°C and 5% CO 2 for 6-8 days. Under a phase-contrast microscope, neurons can be distinguished as presenting with phase bright and compact bodies with very few ramifications, relative to a larger cytoplasm and denser nucleus characteristic of glial cells. Under these conditions, cultures contained approximately 90% glial cells, as additionally confirmed by GFAP immunostaining.
Calcium imaging
Myenteric plexus cultures were incubated in fresh, warm medium containing the fluorescent, cell permeable calcium dye fura-2 acetoxymethyl ester (final concentration 2 lM) for 45 min at 37°C. Cultures were washed with control buffer (118 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl 2 , 10 mM HEPES, 15 mM NaHCO 3 , 11 mM glucose, 0.9 mM NaH 2 PO 3 , 0.8 mM MgSO 4 , pH 7.4) and were then placed in a superfusion chamber. During all experiments, the superfusion conditions were 1 mL/min at 37°C. In experiments in which calcium-free solutions were used, CaCl 2 was removed from the control buffer, and 1 mM EGTA was added. To determine intracellular calcium concentration ([Ca 2+ ] i ), a Zeiss (Thornwood, NY, USA) Axiovert inverted microscope and Attofluor digital imaging system (Rockville, MD, USA) were used. The intracellular calcium concentration was obtained from the ratio of fluorescence intensity of fura-2 at 334 and 380 nm, with an emission wavelength of 540 nm. Calibration of the system was conducted with the following two-point standardization equation using fura-2 free acid: concentration achieved during exposure to the agonist. No differences in the results obtained were observed when neuronal activity was blocked by incubation with 1 lM tetrodotoxin, and therefore the possibility of neuronally mediated effects on glia was discarded.
Tracings shown are representative of experimental observations. Results are presented as mean ± SEM. Data were analyzed by Student's t-test. A value of p < 0.05 was considered significant.
Results
PAR-1 and PAR-2 activation increases [Ca
2+
] i To functionally characterize the presence of PARs, we examined the effects of PAR-1 and PAR-2 activation on the intracellular calcium levels in enteric glial cells. To determine working concentrations, dose-response curves were generated using both the physiological agonist (thrombin or trypsin) and the corresponding specific synthetic peptide (PARP-1 or PARP-2), and the increase in intracellular calcium was quantified with respect to basal levels
Thrombin in a range from 7.3 nM to 7.3 lM (0.001-1.0 U/mL) produced dose-dependent increments in [Ca 2+ ] i (Fig. 1 (Fig. 1c) .
Exposure of cultured enteric glial cells to PARP-1 also caused dose-dependent increases in [Ca 2+ ] i over a concentration range from 10 nM to 2 lM (Fig. 2) . Threshold responses were noted at 10 nM PARP-1. PARP-1 (1 lM) caused increases in [Ca 2+ ] i of 169 ± 6 nM relative to basal levels, with a maximum of 70 ± 11% of cells responding.
Exposure Based on dose-response studies, concentrations of agonists that exerted a submaximal calcium increase were chosen for subsequent experiments. The concentrations of thrombin and PARP-1 used were 0.73 lM (0.1 U/mL) and 100 nM, respectively. To study PAR-2 activation, trypsin and PARP-2 concentrations of 100 nM were used.
Receptor desensitization
To characterize responsiveness after trypsin and thrombin exposure, glial cells were repeatedly exposed to agonist peptides. As shown in Fig. 5 , pretreatment of cells with PARP-1 (100 nM) decreased, but did not eliminate, the response to thrombin. In contrast, exposure of enteric glial cells to thrombin eliminated subsequent responsiveness to a second thrombin application.
Similarly, exposure of glial cells to trypsin (100 nM) eliminated subsequent increases in [Ca 2+ ] i upon secondary exposure to trypsin ( (100 nM) decreased, but did not eliminate, the [Ca 2+ ] i response to secondary trypsin exposure.
To eliminate the possibility of decreased responsiveness due to depletion of intracellular calcium stores, cells were exposed to ATP 100 lM at the end of each experiment (data not shown). All cells responded with D[Ca] i characteristic of this agonist (Kimball and Mulholland 1996) . These results are in accordance with previous observations in which primary exposure to the enzyme (thrombin or trypsin) renders the receptor non-responsive to successive agonist exposure.
PAR receptor activation induced capacitative calcium entry
Capacitative calcium entry (CCE) refers to a process of extracellular calcium influx across the cellular membrane induced by intracellular calcium depletion. CCE is postulated to replenish intracellular stores. To investigate the occurence of CCE, a protocol was followed in which the cells were exposed to agonist in calcium-free buffer, resulting in increased [Ca 2+ ] i secondary to calcium release from intracellular compartments. When [Ca 2+ ] i returned to baseline, calcium was reintroduced in the perfusion buffer, allowing for observation of subsequent CCE. Cells were exposed to PARP-1 or PARP-2 in calcium-free conditions. As shown in Fig. 7 , PARP-1 and PARP-2 increased intracellular calcium levels in absence of extracellular calcium, consistent with release from internal stores. When calcium was returned to the superfusate, subsequent CCE was observed as a secondary increase in [Ca 2+ ] i .
PAR signal transduction
To determine the possible mechanisms through which PAR-1 or PAR-2 activation increase intracellular calcium, the effects of PLC and sphingosine kinase inhibition were investigated. To inhibit PLC activity, the aminosteroid U73122 (1 lM) was added to the perfusion buffer before addition of the corresponding agonist peptide. This compound has been shown to inhibit PLC activity in a variety of cell types (Jin et al. 1994) . As a negative control, U73343 (1 lM), an inactive analog of U73122, was used (data not shown). U73343 was without effect on [Ca 2+ ] i . Dimethylsphingosine (DMS) was used to inhibit sphingosine kinase activity (Edsall et al. 1998) . To demonstrate the specificity of DMS, experiments were performed in which the effects of DMS on ATP-mediated increases in [Ca 2+ ] i were examined. It has been documented previously that ATPmediated increases in [Ca 2+ ] i in enteric glia are solely dependent on PLC activation (Kimball and Mulholland 1996) , and therefore would be expected to be independent of sphingosine kinase activity. Exposure of myenteric glia to DMS 1 lM for 5 min did not affect baseline [Ca 2+ ] i . In addition, pretreatment with DMS did not inhibit increases in [Ca 2+ ] i due to exposure to ATP. PARP-1-mediated increases in [Ca 2+ ] i were significantly attenuated by pretreatment with U73122 (87 ± 6 nM vs. 167 ± 10 nM for controls) (Fig. 8a) . The percentage of cells responsive to the peptide was also decreased by inhibition of PLC (18 ± 7% compared with 56 ± 2%) (Fig. 8b) . Exposure of glial cells to 1 lM DMS did not alter [Ca 2+ ] i increments after PAR-1 exposure.
PARP-2-induced [Ca 2+ ] i increments were decreased from 193 ± 10 to 124 ± 8 nM when glial cells were exposed to U73122 before receptor activation (Fig. 9a) . Pre-exposure of enteroglial cells to 1 lM DMS significantly inhibited responsiveness to PARP-2 (D [Ca 2+ ] i 77 ± 13 mM; 11 ± 1% of cells responding; Fig. 9b ). Inhibitory effects of DMS were dose dependent (data not shown).
Detection of PAR by immunofluorescence
To localize PAR-1 and PAR-2 in our primary cultures, cells were incubated with the relevant primary and secondary antibodies and visualized by confocal laser scanning microscopy (Figs 10a and 10b, respectively) . To verify the glial nature of the cultures, cells obtained identically from the same cultures were stained for the glial marker GFAP. As seen in Fig. 10c and previously reported (Kimball and Mulholland 1996) , the vast majority of the cells in the culture were glial cells. As a negative control, primary antibodies were replaced with antibody solvent (2% serum in ] i and influx from the extracellular space once calcium is returned to the perfusion medium.
phosphate-buffered saline). No staining was observed in the control cultures (Fig. 10d) .
Expression of c-fos in response to PARP-2 To determine if protease exposure increased c-fos expression in enteric glia, primary cultures were exposed to 1 mM PARP-2 for varying lengths of time. Significant and timedependent increase in c-fos immunoreactivity were noted, reaching peak values with 30 min of incubation (Fig. 11) .
Discussion
The present study demonstrates the presence of functionally active PAR-1 and PAR-2 in myenteric glial cells. Five distinct observations support this conclusion.
(i) Glial cells respond dose dependently with increments in [Ca 2+ ] i to both thrombin and trypsin.
(ii) Dose-dependent increases in [Ca 2+ ] i and in the percentage of cells responding were observed with exposure to synthetic PARPs.
(iii) Receptor densensitization typical of PARs was noted with repetitive exposure.
(iv) Enteroglial cells were immunocytochemically positive for PAR-1 and PAR-2.
(v) Exposure to PARP-2 induced significant and timedependent increases in c-fos immunoreactivity in glial cells.
Enteric glial cells also responded to the PAR-2 agonist, tryptase.
Activation of glial PAR-1 or PAR-2 releases Ca 2+ from intracellular stores, with subsequent CCE. The signaling pathway for PAR-1-induced Ca 2+ release involves PLC. In contrast, in enteroglial cells, PAR-2-stimulated Ca 2+ release depends upon both PLC and sphingosine kinase. These observations constitute the first report of PAR expression in enteric glial cells.
The presence of PARs has been demonstrated in a variety of cell systems. Most initial studies of PAR-1 focused on the role of thrombin in wound healing and vessel repair. PAR-1 has been demonstrated in platelets, endothelium, neutrophils and leukocytes, with functional activities linked to cellular aggregation and mucosal barrier function Malik et al. 1986; Andersen et al. 1999) . Recently, PAR-1 expression has been reported in neurons of the ENS (Corvera et al. 1999) . PAR-2 is also widely expressed; it has been demonstrated in vascular tissue, the digestive system and epidermis (Al-Ani et al. 1995 21 ; Santulli et al. 1995; Derian and Eckardt 1997; D'Andrea et al. 1998; Corvera et al. 1999) . Within the gastrointestinal tract, PAR-2 has been reported in enterocytes, smooth muscle cells and myenteric neurons. Our observations indicate that both PAR-1 and PAR-2 are present in myenteric glia.
Activation of both PAR-1 and PAR-2 has been associated with increases in [Ca 2+ ] i in different cell types, through G-protein-mediated activation of different calcium signaling cascades (Wang et al. 1996; Brass et al. 1993; Corvera et al. 1999) . The intracellular origin of the initial calcium increase has been demonstrated in epithelial cell and myenteric neurons, where activation of these receptors induces increased [Ca 2+ ] i 22 in absence of extracellular calcium (Bohm et al. 1996; Corvera et al. 1999) .
The specificity of agonist peptides PARP-1 and PARP-2 has been demonstrated previously in different models, mimicking thrombin and trypsin receptor action, respectively (Chao et al. 1992; Hollenberg et al. 1997; Vergnolle et al. 1998; Corvera et al. 1999) . PARs demonstrate a unique mechanism of receptor activation through cleavage at the N-terminus. This receptor cleavage is believed to contribute to receptor desensitization, making the modified receptor molecule non-responsive to a second exposure to protease. This mechanism of desensitization has been noted in previous reports in which primary exposure to trypsin or thrombin abolished subsequent responsiveness to the proteases. In contrast, primary exposure to PARP-1 or PARP-2 results in diminished, but still present, responsiveness to repeated exposure to the synthetic peptides (Hammes and Coughlin 1999; Corvera et al. 1999) . Detailed study of PAR-1 and PAR-2 signaling in enteroglial cells has indicated that receptor activation leads to rapid release of calcium from intracellular stores, followed by secondary influx of calcium from extracellular sources. This secondary process has been termed CCE. CCE is typical for calcium signaling in a variety of nonexcitable cells, and has been demonstrated previously in enteroglial cells (Zhang et al. 1997; Sarosi et al. 1998 ). CCE appears to modulate a wide range of biological pathways, such as proliferation, regulation of adenylate cyclase and hormonal regulation. It may serve to replenish internal stores previously depleted by calcium-mobilizing agonists such as inositol trisphosphate (IP3) (Berridge 1995) .
The current investigation indicates that the cellular intermediates that participate in PAR-1 and PAR-2 calcium signaling in enteroglia differ. PAR-1-induced Ca 2+ transients were significantly diminished by PLC inhibition, but were unaffected by DMS, an inhibitor of sphingosine kinase. PAR-1 has been shown previously to couple to PLC, stimulating IP3 production, and release of calcium from IP3-sensitive intracellular stores (Babich et al. 1990; Garcia 1992; Hung et al. 1992) .
In contrast, calcium signaling in response to PAR-2 activation was decreased by inhibition of both PLC and sphingosine kinase. There are previous reports that suggest that PAR-2 signaling occurs through PLC activation in enterocytes and smooth muscle cells, among others (Kong et al. 1997; Berger et al. 2001) . Sphingosine kinase catalyzes the intracellular phosphorylation of sphingosine to produce sphingosine-1-phosphate (S1P). Production of S1P and subsequent calcium release has been observed after activation of several membrane receptors (Choi et al. 1996) . These effects are blocked by sphingosine kinase inhibitors, demonstrating the involvement of S1P production in the reported calcium transient. DMS is a newly described sphingosine kinase inhibitor (Edsall et al. 1998 ) that shows higher specificity than previously used inhibitory compounds. The current investigation is the first report of the involvement of S1P in PAR-2 signaling. S1P is a versatile molecule that can act extracellularly by binding to G-protein-coupled membrane receptors, as well as intracellularly, as a second messenger stimulating calcium release from the endoplasmic reticulum (Ghosh et al. 1994 ; were detected by immunofluorescence in glial cultures. 4¢,6-Diamidino-2-phenylindole (DAPI) 25 was used as nuclear counterstain. Additionally, identical cultures were characterized using GFAP as a glial marker (c). Control cultures lacking primary antibody incubation showed no significant staining (d). Postma et al. 1996) . The effects of S1P in other systems have been related to control of cell proliferation and migration (Zhang et al. 1990 ). It has recently been reported that intracellular S1P is involved in thrombin-stimulated histamine release from mast cells (Gordon et al. 2000) . The mechanisms governing PAR signaling may vary, depending upon the system studied (Grand et al. 1996) .
The physiologic role of PAR signaling in enteric glial cells is unknown. The recent finding of a thrombin-generating system in the brain and the presence of PAR-1 in neurons and glia suggest that PAR-1 may have functions in addition to revascularization (Ubl et al. 1998) . PAR-2 activation has been related to release of proteinases in inflammatory and allergic conditions, vasodilatation of cerebral arteries, release of prostaglandins, and regulation of cytokine production in enterocytes (Wakita et al. 1997; Sobey et al. 1999) . In the gastrointestinal tract, PAR-2 may be activated by trypsin or tryptase, presumably released by mast cells within the gut wall (Corvera et al. 1999) . The widespread localization of PAR-1 and PAR-2 within the digestive tract makes them an attractive target for functional investigation. 
